Role of IRS-1-GRB-2 complexes in insulin signaling - PubMed (original) (raw)
Role of IRS-1-GRB-2 complexes in insulin signaling
M G Myers Jr et al. Mol Cell Biol. 1994 Jun.
Abstract
GRB-2 is a small SH2- and SH3 domain-containing adapter protein that associates with the mammalian SOS homolog to regulate p21ras during growth factor signaling. During insulin stimulation, GRB-2 binds to the phosphorylated Y895VNI motif of IRS-1. Substitution of Tyr-895 with phenylalanine (IRS-1F-895) prevented the IRS-1-GRB-2 association in vivo and in vitro. The myeloid progenitor cell line, 32-D, is insensitive to insulin because it contains few insulin receptors and no IRS-1. Coexpression of IRS-1 or IRS-1F-895 with the insulin receptor was required for insulin-stimulated mitogenesis in 32-D cells, while expression of the insulin receptor alone was sufficient to mediate insulin-stimulated tyrosine phosphorylation of Shc and activation of p21ras and mitogen-activated protein (MAP) kinase. The Shc-GRB-2 complex formed during insulin stimulation is a possible mediator of p21ras and MAP kinase activation in IRS-1-deficient 32-D cells. Interestingly, IRS-1, but not IRS-1F-895, enhanced the stimulation of MAP kinase by insulin in 32-D cells expressing insulin receptors. Thus, IRS-1 contributes to the stimulation of MAP kinase by insulin, probably through formation of the IRS-1-GRB-2 complex at Tyr-895. Our results suggest that the Shc-GRB-2 complex and the activation of p21ras-dependent signaling pathways, including MAP kinase, are insufficient for insulin-stimulated mitogenesis and that the essential function(s) of IRS-1 in proliferative signaling is largely unrelated to IRS-1-GRB-2 complex formation.
Similar articles
- Insulin receptor substrate 1 rescues insulin action in CHO cells expressing mutant insulin receptors that lack a juxtamembrane NPXY motif.
Chen D, Van Horn DJ, White MF, Backer JM. Chen D, et al. Mol Cell Biol. 1995 Sep;15(9):4711-7. doi: 10.1128/MCB.15.9.4711. Mol Cell Biol. 1995. PMID: 7651388 Free PMC article. - Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation.
Noguchi T, Matozaki T, Horita K, Fujioka Y, Kasuga M. Noguchi T, et al. Mol Cell Biol. 1994 Oct;14(10):6674-82. doi: 10.1128/mcb.14.10.6674-6682.1994. Mol Cell Biol. 1994. PMID: 7935386 Free PMC article. - The new elements of insulin signaling. Insulin receptor substrate-1 and proteins with SH2 domains.
Myers MG Jr, White MF. Myers MG Jr, et al. Diabetes. 1993 May;42(5):643-50. doi: 10.2337/diab.42.5.643. Diabetes. 1993. PMID: 8387037 Review. - Inputs and outputs of insulin receptor.
Du Y, Wei T. Du Y, et al. Protein Cell. 2014 Mar;5(3):203-13. doi: 10.1007/s13238-014-0030-7. Epub 2014 Mar 16. Protein Cell. 2014. PMID: 24633815 Free PMC article. Review.
Cited by
- Next-Cell Hypothesis: Mechanism of Obesity-Associated Carcinogenesis.
Engin AB, Engin A. Engin AB, et al. Adv Exp Med Biol. 2024;1460:727-766. doi: 10.1007/978-3-031-63657-8_25. Adv Exp Med Biol. 2024. PMID: 39287871 Review. - Neddylation of insulin receptor substrate acts as a bona fide regulator of insulin signaling and its implications for cancer cell migration.
Park JB, Moon GH, Cho A, Kwon M, Park JW, Yi EC, Kim H, Fukuda J, Kwak C, Ko YG, Chun YS. Park JB, et al. Cancer Gene Ther. 2024 Apr;31(4):599-611. doi: 10.1038/s41417-024-00729-z. Epub 2024 Jan 25. Cancer Gene Ther. 2024. PMID: 38272982 Free PMC article. - Insulin signaling in development.
Suzawa M, Bland ML. Suzawa M, et al. Development. 2023 Oct 15;150(20):dev201599. doi: 10.1242/dev.201599. Epub 2023 Oct 17. Development. 2023. PMID: 37847145 Free PMC article. - Is Insulin Receptor Substrate4 (IRS4) a Platform Involved in the Activation of Several Oncogenes?
Guijarro LG, Justo Bermejo FJ, Boaru DL, De Castro-Martinez P, De Leon-Oliva D, Fraile-Martínez O, Garcia-Montero C, Alvarez-Mon M, Toledo-Lobo MDV, Ortega MA. Guijarro LG, et al. Cancers (Basel). 2023 Sep 20;15(18):4651. doi: 10.3390/cancers15184651. Cancers (Basel). 2023. PMID: 37760618 Free PMC article. Review. - The Impact of ETV6-NTRK3 Oncogenic Gene Fusions on Molecular and Signaling Pathway Alterations.
Kinnunen M, Liu X, Niemelä E, Öhman T, Gawriyski L, Salokas K, Keskitalo S, Varjosalo M. Kinnunen M, et al. Cancers (Basel). 2023 Aug 24;15(17):4246. doi: 10.3390/cancers15174246. Cancers (Basel). 2023. PMID: 37686522 Free PMC article.
References
- Mol Cell Biol. 1990 Jun;10(6):3204-15 - PubMed
- Mol Cell Biol. 1993 Dec;13(12):7418-28 - PubMed
- Nature. 1991 Jul 4;352(6330):73-7 - PubMed
- Methods Enzymol. 1991;201:65-79 - PubMed
- Mol Cell Biol. 1991 Dec;11(12):5963-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous